2013 Pulmonary & Allergy Update

DENVER —

Nationally recognized faculty from National Jewish Health will discuss insights and recent advances in pulmonary medicine, asthma, allergies and immunology at the 35th Annual Pulmonary & Allergy Update at Keystone, Feb. 6-9. Topics will range from nutrition and asthma to the allergic impact of global warming, allergies to joint replacements and new dietary recommendations for food allergy.

Below are short summaries of several presentations. Download the complete agenda. For more information, contact William Allstetter at allstetterw@njhealth.org or 303.398.1002.


Explaining the Asthma Epidemic: You Are What You Eat. (4 p.m., Feb. 6) Rand Sutherland, MD, MPH, will discuss emerging evidence on the role of nutrition in asthma, including recent findings on folate, vitamin D, Tylenol and obesity.

The Allergic Impact of Global Warming. (7 a.m., Feb 8) Richard Weber, MD, will discuss evidence that a warming globe has already lengthened the allergy season and increased pollen levels, two trends that are likely to continue.

Update on Food Allergy. (7:40 a.m., Feb 8) David Fleischer, MD, will discuss new recommendations for timing the introduction of potentially allergenic foods into infants’ diets, as well as immunotherapy to desensitize food-allergic patients, and a new epinephrine injector.

Allergy to Metal and Cement in Joint Replacement. (7:40 a.m., Feb 9) Karin Pacheco, MD, MSPH, discusses allergies to metal and cement that can cause failure of prosthetic hips and knees, as well as new tests to detect the most common metal allergy – nickel.

Is Asthma an Infectious Disease? (7:40 a.m. Feb. 7) Richard Martin, MD, will discuss the role of bacterial and viral infections in asthma and their relation to the “hygiene hypothesis” to explain the dramatic rise in asthma in recent decades.

Why Does My Patient’s Asthma Not Respond to Inhaled Corticosteroids? (9:30 a.m., Feb 8) Erwin Gelfand, MD, explains various reasons for poor asthma control with inhaled corticosteroids, from steroid insensitivity to poor adherence, poor technique or poor perception.

National Jewish Health is the leading respiratory hospital in the nation. Founded 125 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of children and adults with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit the media resources page.

We have many faculty members, from bench scientists to clinicians, who can speak on almost any aspect of respiratory, immune, cardiac and gastrointestinal disease as well as lung cancer and basic immunology.

Our team is available to arrange interviews, discuss events and story ideas.

Make an Appointment